Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: paclitaxel
Drug: topotecan hydrochloride
Radiation: radiation therapy

First Posted Date: 2003-09-24

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 84

Registration Number: NCT00003281

Locations: 🇺🇸
CCOP - Ochsner, New Orleans, Louisiana, United States
🇺🇸
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

and more 16 locations

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Completed

Conditions: Psychosocial Effects of Cancer and Its Treatment
Breast Cancer

Interventions: Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment

First Posted Date: 2003-09-11

Last Posted Date: 2017-08-08

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1706

Registration Number: NCT00068328

Locations: 🇺🇸
Elkhart Clinic, LLC, Elkhart, Indiana, United States
🇺🇸
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center, Pinehurst, North Carolina, United States
🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States

and more 81 locations

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Phase 2

Terminated

Conditions: Melanoma (Skin)
Metastatic Cancer

Interventions: Drug: temozolomide
Radiation: radiation therapy

First Posted Date: 2003-09-11

Last Posted Date: 2016-12-15

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 41

Registration Number: NCT00068666

Locations: 🇺🇸
John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Mercy Capitol Hospital, Des Moines, Iowa, United States

and more 42 locations

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase 3

Completed

Conditions: Neurotoxicity
Pain
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: Placebo
Drug: lamotrigine

First Posted Date: 2003-09-11

Last Posted Date: 2018-05-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 131

Registration Number: NCT00068445

Locations: 🇺🇸
Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center, Sioux City, Iowa, United States
🇺🇸
Coborn Cancer Center, Saint Cloud, Minnesota, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

and more 20 locations

Lycopene in Treating Patients With Metastatic Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Dietary Supplement: lycopene

First Posted Date: 2003-09-11

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 47

Registration Number: NCT00068731

Locations: 🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

and more 15 locations

Combination Chemotherapy in Treating Patients With Colorectal Cancer

Phase 3

Completed

Conditions: Colorectal Cancer

Interventions: Drug: fluorouracil
Drug: irinotecan hydrochloride
Drug: leucovorin calcium

First Posted Date: 2003-09-03

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 400

Registration Number: NCT00006103

Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2

Completed

Conditions: Leukemia

Interventions: Drug: ara-C
Biological: gemtuzumab ozogamicin

First Posted Date: 2003-09-03

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 60

Registration Number: NCT00006265

Locations: 🇺🇸
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
🇺🇸
Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States
🇺🇸
CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States

and more 75 locations

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

Completed

Conditions: Leukemia

Interventions: Genetic: reverse transcriptase-polymerase chain reaction

First Posted Date: 2003-08-20

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 9769

Registration Number: NCT00003931

Locations: 🇺🇸
University of California San Diego Cancer Center, La Jolla, California, United States
🇺🇸
Mount Sinai Medical Center, NY, New York, New York, United States
🇺🇸
CCOP - Christiana Care Health Services, Wilmington, Delaware, United States

and more 43 locations

Hormone Therapy in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer
Sexual Dysfunction and Infertility

Interventions: Drug: finasteride
Drug: flutamide
Other: quality-of-life assessment

First Posted Date: 2003-08-13

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 101

Registration Number: NCT00003323

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸
University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

and more 40 locations

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

Completed

Conditions: Lung Cancer

Interventions: Genetic: reverse transcriptase-polymerase chain reaction
Other: immunohistochemistry staining method

First Posted Date: 2003-08-13

Last Posted Date: 2016-06-29

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 501

Registration Number: NCT00003006

Locations: 🇺🇸
Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

and more 7 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy